Pet Pharm Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	3,091	3,585	1,656	-	-
Market Cap Growth	8.45%	116.51%	-	-	-
Enterprise Value	2,700	3,187	1,535	-	-
Last Close Price	54.00	70.00	39.48	-	-
PE Ratio	117.39	143.47	114.14	-	-
PS Ratio	13.92	16.14	12.67	-	-
PB Ratio	2.58	3.00	2.84	-	-
P/TBV Ratio	2.86	3.32	2.89	-	-
P/FCF Ratio	645.35	748.49	-	-	-
P/OCF Ratio	90.11	104.52	57.32	-	-
EV/Sales Ratio	12.16	14.35	11.75	-	-
EV/EBITDA Ratio	56.56	83.45	78.93	-	-
EV/EBIT Ratio	183.09	216.15	189.22	-	-
EV/FCF Ratio	563.69	665.45	-	-	-
Debt / Equity Ratio	0.09	0.09	0.25	0.12	0.32
Debt / EBITDA Ratio	2.22	2.22	5.45	1.99	4.49
Debt / FCF Ratio	22.17	22.17	-	5.97	-
Net Debt / Equity Ratio	-0.34	-0.34	-0.42	-0.29	0.19
Net Debt / EBITDA Ratio	-10.81	-10.81	-12.55	-6.41	2.72
Net Debt / FCF Ratio	-86.18	-86.18	1.53	-14.89	-0.92
Asset Turnover	0.21	0.21	0.21	0.35	-
Inventory Turnover	7.46	7.46	4.96	6.42	-
Quick Ratio	10.28	10.28	3.01	6.18	1.94
Current Ratio	10.68	10.68	3.16	10.97	5.05
Return on Equity (ROE)	2.80%	2.80%	2.91%	3.34%	-
Return on Assets (ROA)	0.88%	0.88%	0.81%	1.40%	-
Return on Capital Employed (ROCE)	1.10%	1.10%	1.30%	1.70%	-2.80%
Earnings Yield	0.81%	0.70%	0.88%	-	-
FCF Yield	0.15%	0.13%	-9.63%	-	-
Dividend Yield	0.46%	0.36%	0.23%	-	-
Payout Ratio	20.22%	20.22%	55.42%	-	-
Buyback Yield / Dilution	-32.26%	-32.26%	-37.19%	-23.19%	-
Total Shareholder Return	-31.80%	-31.90%	-36.96%	-23.19%	-